The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

 

Lung cancer: Molecular scissors determine therapy effectiveness

non-small-cell1Clinical studies of non-small cell lung cancer, which is the most frequent type of lung cancer, have shown so far that only part of the patients treated with cetuximab benefit from the treatment. Therefore, doctors are urgently searching for biomarkers which reliably predict responsiveness to the antibody therapy.

 

Trackback

 

Leave a Reply